Focused team with clearly defined responsibilities

Board of Directors

Chief Executive Officer (CEO)
Member of the Executive Board
Dr. Harry Flore

Working for HAL Allergy since 2007. Over 20 years of experience in the pharmaceutical industry in the USA and Europe with broad knowledge of quality systems (GMP, ISO) and proven leadership skills in both scientific and production settings.

Get in touch via: LinkedIn

 

 

Chief Commercial & Financial Officer (CCFO)
Member of the Executive Board
Florian Rösch

Working for HAL Allergy since 2016. Over 10 years experience in different industries across Europe and Asia with leadership skills and track record in finance, strategy, sales, production and operations. Dedicated focus on long-term value enhancement and operational excellence.

Get in touch via: LinkedIn / Xing

 

 

Chief Operations Officer (COO)
Member of the Executive Board
Eize de Boer

Working for HAL-Allergy since 2015. Biotech expert with over 25 years of experience in the biopharmaceutical sector worldwide. PhD degree in biochemistry, with business and quality certifications in pharmaceutical supply chain management. Extensive experience with a vast number of quality schemes like GMP/GDP. Regulatory and organizational leadership biopharmaceutical Process Development and project/line management.

Get in touch via: LinkedIn

 

Chief Scientific Officer (CSO)
Member of the Executive Board
Dirk Jan Opstelten

Working for HAL Allergy since 2008, previously in the position of Director Research & Development. Over 20 years experience in leading R&D programs in biotechnology and pharmaceutical product development. (Co-)author of various scientific publications and inventor of patent applications and granted patents in the field of allergy, virology and biotechnology innovations.

                                            Get in touch via: LinkedIn